Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Tilray Brands Inc TLRY

Alternate Symbol(s):  T.TLRY

Tilray Brands, Inc. is a global lifestyle and consumer packaged goods company. The Company operates through four segments: Cannabis operations, Distribution business, Beverage alcohol business and Wellness business. The Cannabis operations, which encompasses the production, distribution, sale, co-manufacturing and advisory services of both medical and adult-use cannabis. The Beverage alcohol operations, which encompasses the production, marketing and sale of beverage alcohol products. The Distribution operations, which encompasses the purchase and resale of pharmaceuticals products to customers. The Wellness products, which encompasses hemp foods and cannabidiol (CBD) products. The Company offers a portfolio of adult-use brands and products and expands its portfolio to include new cannabis products and formats. Its brands include Good Supply, RIFF, Broken Coast, Solei, Canaca, HEXO, Redecan, Original Stash, Hop Valley, Revolver, Bake Sale, XMG, Mollo, and others.


NDAQ:TLRY - Post by User

Comment by DuDliedingleon Nov 20, 2024 7:16pm
40 Views
Post# 36322809

RE:hey quinlash - Tikray (over)paid for Hexo, spending

RE:hey quinlash - Tikray (over)paid for Hexo, spending
Keeler wrote: $250 million on the company that would have had to declare bankrutcy if not for the acquisition.
This is not disputed - and reflected in Tikray's filing.

I've told you before that Hexo accounts for less than $10 million Net Revenue
When you subtract the Cost of Goods Sold (60%) required to produce Hexo products, you're left with a Gross Profit of $4 million quarterly.

From that $4 million Gross Profit - Operating Expenses are then deducted to arrive at a NET LOSS.

Tikray investors spent $250 million on a company from which they will NEVER recover the investment. They did just as well with Hexo as with the $225 million spent on Medmen.

Meanwhile, Simple Simon has taken in $66 million compensation in the last 3 years.

Score:
Simple Simon                 $ 66 million
Investors                            zero           (who knows what the actual net losses have been)




 

You realize that some shareholders would not know how to have come to this conclusion or anything like it. 

This would not be on Tilrays website or explained in any press releases. But even if they were to jig it to be positive say 1 million per quarter. That time frame is longer than any of us are gonna live even if Elon Musk gets us some cryogenics.

Thanks for explaining this in a simple form that should make it easier to understand.  
<< Previous
Bullboard Posts
Next >>